摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester

中文名称
——
中文别名
——
英文名称
4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester
英文别名
cis-4-[(3,5-Bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester;propan-2-yl 4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonylamino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2H-quinoline-1-carboxylate
4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester化学式
CAS
——
化学式
C27H30F6N2O6
mdl
——
分子量
592.535
InChiKey
JKVXTXJMOAQSGD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    41
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    77.5
  • 氢给体数:
    0
  • 氢受体数:
    12

文献信息

  • 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
    申请人:Pfizer Products Inc.
    公开号:EP0987251B1
    公开(公告)日:2004-05-19
  • PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF DRUGS AND NEUTRAL POLYMERS
    申请人:Pfizer Products Inc.
    公开号:EP1404300A1
    公开(公告)日:2004-04-07
  • PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
    申请人:Bend Research, Inc.
    公开号:EP2258352B1
    公开(公告)日:2015-05-13
  • US6140342A
    申请人:——
    公开号:US6140342A
    公开(公告)日:2000-10-31
  • [EN] PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF DRUGS AND NEUTRAL POLYMERS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES DE DISPERSIONS DE MEDICAMENTS ET DE POLYMERES NEUTRES
    申请人:PFIZER PROD INC
    公开号:WO2003000235A1
    公开(公告)日:2003-01-03
    In one aspect, pharmaceutical compositions comprising dispersions of an acid-sensitive drug and a neutral dispersion polymer are disclosed. The acid-sensitive drug has improved chemical stability relative to dispersions of the drug and acidic polymers. In another aspect, pharmaceutical compositions of low solubility drugs and amphiphilic, hydroxy-functional vinyl copolymers are disclosed.
查看更多